Changes in Vascular Permeability and Expression of Different Angiogenic Factors Following Anti-Angiogenic Treatment in Rat Glioma

BACKGROUND: Anti-angiogenic treatments of malignant tumors targeting vascular endothelial growth factor receptors (VEGFR) tyrosine kinase are being used in different early stages of clinical trials. Very recently, VEGFR tyrosine kinase inhibitor (Vetanalib, PTK787) was used in glioma patient in conj...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Meser M., Janic, Branislava, Babajani-Feremi, Abbas, Varma, Nadimpalli R. S., Iskander, A. S. M., Anagli, John, Arbab, Ali S.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806917/
https://www.ncbi.nlm.nih.gov/pubmed/20090952
http://dx.doi.org/10.1371/journal.pone.0008727

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806917/
https://www.ncbi.nlm.nih.gov/pubmed/20090952
http://dx.doi.org/10.1371/journal.pone.0008727

Ejemplares similares